drugset / Trial / NCT01529229

Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment

NCT01529229

Phase 3 Completed 210 enrolled EMS
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the treatment of Moderate - Severe Persistent Allergic Rhinitis.

Timeline

Start
2013-11
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 0.05 mg/ml
Subject Desloratadine Small molecule 0.5 mg/ml Oral
Comparator Dexchlorpheniramine Unknown 0.4 mg/ml
Subject Prednisolone Other / unclassified 4 mg/ml Oral

Indications